Harvard Scientific (HVSF)Hot$$- male impotency medicine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hal who wrote (2730)	1/16/1998 9:16:00 AM
From: Krukov	Read Replies (2) of 3906

Hal: Thank you for the average price calculations. It's always easier to make a real determination of the value of a deal when you have the numbers. Based on the prices that you provided, HVSF will end up with an additional 21.7 million shares. This is on top of the already 30 million (approximately) shares that HVSF currently has outstanding. I understand that it is difficult for the company to get financing, however if Waite and See will be able to trade these shares immediately, then this not such a shareholder friendly deal. to demonstrate their cpommitment to the company, the least they can do is to restrict these shares for a certain period, at least 3 years for example. JMO. Krukov

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next